Skip to content

Studying the Effect of a Herbal Syrup (Sharbat Ustukhuddus) on Long-Term Sinus Problems

To Evaluate the Efficacy of Sharbat-e-Ustukhuddus in the management of Waram Tajawif al-Anf Muzmin (Chronic Rhinosinusitis): An open label interventional clinical study - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/07/092121
Enrollment
40
Registered
2025-07-31
Start date
Unknown
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J329- Chronic sinusitis, unspecified

Interventions

Intervention1: Sharbat Ustukhuddus: Patients will be given Sharbat Ustukhuddus 20 ml twice a day for 6 weeks. Control Intervention1: Not Applicable: Not Applicable

Sponsors

State Unani Medical College and HAHRDM Hospital Himmatganj Prayagraj
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Mild to Moderate case of Chronic Rhinosinusitis 2 Duration of the disease More Than 12 weeks 3 Patient having at least two out of four cardinal symptom (facial pain/pressure, hyposmia or anosmia, nasal obstruction, and nasal discharge for at least 12 consecutive weeks 4 Patient having any of the following symptoms like rhinorrhea, nasal congestion, frontal headache, nasal itching, impaired sense of smell and frequent sneezing for more than 12 weeks 5 X-ray PNS with Positive finding (Thickened mucosal lining, opacity of sinus)

Exclusion criteria

Exclusion criteria: 1 Patient aged less than 18years or more than 50years. 2 Patient with deviated nasal septum (DNS). 3 Local pathology such as mucocele, cyst, Antrochoanal polyp, facial trauma. 4 Diabetes mellitus and any other illness requiring long term treatment. 5 Pregnant or Lactating Women. 6 Significant Pulmonary or Cardiovascular or Hepatorenal Dysfunction. 7 Patient not willing to attend regular treatment and follow-up for the entire duration of study. 8 Patient having history of any surgery of nose or paranasal sinuses. 9 Patient having history of trauma to nose or sinus area. 10 Patient of pulmonary Koch s or having history of epistaxis. 11 Any medical condition where physician feels that participation in the study could be detrimental to patient s wellbeing.

Design outcomes

Primary

MeasureTime frame
Visual Analog Scale(VAS) SNOT-22:CRSspecificQoLTimepoint: 2nd, 4th, and 6th Week from baseline.

Secondary

MeasureTime frame
X-RAY (PNS)- Water s View AEC(Absolute Eosinophil Count)Timepoint: 2nd, 4th, and 6th Week from baseline.

Countries

India

Contacts

Public ContactMohd Salman

State Unani Medical College Himmatganj Prayagraj Uttar Pradesh Pin Code 211016

asifhussainusmani@gmail.com7905831926

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026